NovaBay Pharmaceuticals (NBY) Q3 2024 Earnings

13AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-5.25
-3.62
-2
-0.37

Details

Expected EPS
-1.225
Actual EPS
-1.37
Surprise EPS
-0.15
Surprise Percent
+11.84%

Description

NovaBay Pharmaceuticals (NBY) has reported earnings of -1.37 per share for Q3 2024.

0 Comments

Share your thoughts